Morning Briefing
Summaries of health policy coverage from major news organizations
Abbott Challenges Copies Of Its Biologic Drugs
Drugmaker Abbott is challenging the manufacture of copies of its biologic drugs, including the potential world's number one selling drug this year, Humira.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
